ARCHIVES

Also von Eschenbach Role in Industry Program Raises New Concerns of Conflict of Interest.

This article is from The Cancer Letter archive.

Vol. 32 No. 42 | November 22, 2006

Download PDF Visit The Full Archive

Related Articles

FDA News: Tentative Approval Given IVAX Paxene; BMS Exclusivity Upheld

January 9, 1998

NCI’s Richard Kaplan named associate director, National Cancer Research Network of UK.

January 2, 2004

Tarceva Added To Gemcitabine Improves Pancreatic Cancer Survival, Study Finds

February 25, 2005

Seattle Times, The Hutch Duel Over Five-Part Series.

March 23, 2001

Ruckdeschel To Direct Nevada Cancer Institute

February 6, 2009

In Brief: AMA Opposes Bill To Permit Heroin Use For Pain Control, Says Morphine Is Equally As Effective

March 23, 1984